Geode Capital Management’s CNS Pharmaceuticals CNSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7K | Buy |
+17,871
| New | +$14.7K | ﹤0.01% | 4396 |
|
|
2025
Q1 | – | Sell |
-387,064
| Closed | -$46.6K | – | 4486 |
|
|
2024
Q4 | $46.6K | Buy |
387,064
+183,884
| +91% | +$22.1K | ﹤0.01% | 4254 |
|
|
2024
Q3 | $26.5K | Buy |
+203,180
| New | +$26.5K | ﹤0.01% | 4367 |
|
|
2024
Q2 | – | Sell |
-28,254
| Closed | -$10.2K | – | 4593 |
|
|
2024
Q1 | $10.2K | Buy |
28,254
+3,818
| +16% | +$1.38K | ﹤0.01% | 4551 |
|
|
2023
Q4 | $30.8K | Hold |
24,436
| – | – | ﹤0.01% | 4449 |
|
|
2023
Q3 | $27.4K | Buy |
24,436
+8,294
| +51% | +$9.29K | ﹤0.01% | 4561 |
|
|
2023
Q2 | $36K | Buy |
+16,142
| New | +$36K | ﹤0.01% | 4573 |
|
|
2022
Q4 | – | Sell |
-129,016
| Closed | -$23K | – | 4904 |
|
|
2022
Q3 | $23K | Hold |
129,016
| – | – | ﹤0.01% | 4894 |
|
|
2022
Q2 | $36K | Hold |
129,016
| – | – | ﹤0.01% | 4846 |
|
|
2022
Q1 | $43K | Buy |
129,016
+21,754
| +20% | +$7.25K | ﹤0.01% | 4830 |
|
|
2021
Q4 | $75K | Hold |
107,262
| – | – | ﹤0.01% | 4792 |
|
|
2021
Q3 | $159K | Buy |
107,262
+7,066
| +7% | +$10.5K | ﹤0.01% | 4525 |
|
|
2021
Q2 | $196K | Buy |
100,196
+39,412
| +65% | +$77.1K | ﹤0.01% | 4349 |
|
|
2021
Q1 | $145K | Buy |
+60,784
| New | +$145K | ﹤0.01% | 4210 |
|